ADORA2B and triple-negative breast carcinoma: Triterpene glycosides Cuc A0-1 and Dj A were identified as novel antagonists of the adenosine A2B receptor (A2BAR), which is overexpressed in triple-negative breast cancer MDA-MB-231 cells.